ORIGINAL RESEARCH
Published on 01 Oct 2026
Identification of Akkermansia muciniphila as a candidate gut commensal involved in the pathogenesis of rheumatoid arthritis
doi 10.3389/fimmu.2026.1917757
- 706 views
Articles
ORIGINAL RESEARCH
Published on 13 Aug 2026
Artemisinin ameliorates rheumatoid arthritis through modulation of the IL-17/PI3K/AKT signaling pathway: integrated network pharmacology, bioinformatics, and experimental validation
doi 10.3389/fimmu.2026.1862104
- 942 views
REVIEW
Published on 22 Jul 2026
FGF/FGFR signaling at the immune-stromal interface in autoimmune rheumatic diseases: from tissue remodeling to translational opportunities
doi 10.3389/fimmu.2026.1875220
- 1,052 views
ORIGINAL RESEARCH
Published on 22 Jul 2026
Dysregulated expression of PSGL-1 and ADAM8 in Sjögren’s disease: potential contribution to disease pathogenesis
doi 10.3389/fimmu.2026.1848689
- 1,036 views
ORIGINAL RESEARCH
Published on 03 Jul 2026
HLA class I-naturally presented synovial tissue peptides are recognized by CD8+ T lymphocytes from rheumatoid arthritis patients
doi 10.3389/fimmu.2026.1843318
- 1,694 views
MINI REVIEW
Published on 01 Jul 2026
JAK inhibitors in rheumatoid arthritis-associated interstitial lung disease: a review of mechanisms and clinical evidence
doi 10.3389/fimmu.2026.1784714
- 1,796 views
CASE REPORT
Published on 29 May 2026
Successful 6-year follow-up of treatment for IgA nephropathy complicated by IgA-λ monoclonal gammopathy with multi-system damage: a case report
doi 10.3389/fimmu.2026.1815188
- 1,468 views
ORIGINAL RESEARCH
Published on 15 Apr 2026
Genome-wide gene expression analysis suggests an important regulatory role of lncRNAs in primary Sjögren’s syndrome
doi 10.3389/fimmu.2026.1751195
- 1,263 views
- 1 citation
ORIGINAL RESEARCH
Published on 17 Mar 2026
Plasma miR-134-5p: a candidate biomarker for predicting non-response to anti-TNF therapy in rheumatoid arthritis
doi 10.3389/fimmu.2026.1783026
- 1,585 views
ORIGINAL RESEARCH
Published on 09 Mar 2026
A curcumin-borneol prodrug delays rheumatoid arthritis progression by inhibiting the activation of the MAPK/AP-1-MMP9 inflammatory axis
doi 10.3389/fimmu.2026.1775735
- 1,621 views
- 1 citation
REVIEW
Published on 04 Mar 2026
B cell receptor signaling in autoimmune rheumatic diseases: regulatory mechanisms and therapeutic targeting
doi 10.3389/fimmu.2026.1750557
- 3,707 views
- 3 citations
REVIEW
Published on 27 Feb 2026
Advances in the study of low-density neutrophils in rheumatic diseases
doi 10.3389/fimmu.2026.1747583
- 1,730 views
- 3 citations
